For years physicians have been taught to target the FBS in their diabetic patients. Dr. Shira Johnson interviews Dr. Stephen Colaguiri from the International Diabetes Federation whose recent work shows that this is not enough.
Diabetes: Is Controlling the FBS Enough?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
For years physicians have been taught to target the FBS in their diabetic patients. Dr. Shira Johnson interviews Dr. Stephen Colaguiri from the International Diabetes Federation whose recent work shows that this is not enough.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?